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Open access undBackground and purpose: In the late 1990s a period of shortage of radiotherapy capacity caused long wait-
ing times in The Netherlands. Investments in treatment vaults, equipment and training capacity were
made. The developments since then are described and the actual situation is compared with the predic-
tions throughout the years.
Method and materials: Data are based on annual surveys on production, personnel and equipment of all
21 Dutch radiotherapy centers.
Results: An annual increase in patients, radiotherapy treatments and a corresponding increase in equip-
ment and personnel was seen, on average 3.5–4% per year. After an initial shift to more 3D conformal
treatments, a subsequent change from 3D conformal to intensity modulated and image guided tech-
niques was observed. There has been no increase in the number of radiotherapy centers and the average
size of a Dutch department in 2010 was 5.7 linacs, 10.4 fte radiation oncologists, 4.8 fte physicists and
45.8 fte technologists.
Conclusions: The number of linacs increased as anticipated. The increase in stafﬁng was in balance with
the need, resulting in only a limited number of vacancies. In 2010 there were virtually no waiting lists,
and no overcapacity. The predicted need and the actual number of radiotherapy treatment series per year
correspond very well. A national program for a planned increase of radiotherapy capacity is feasible.
Expansion of existing departments instead of increasing the number allows for a more rapid introduction
of new technologies and sufﬁcient subspecialization of the staff.
 2013 Elsevier Ireland Ltd. Open access under the Elsevier OA license.
Radiotherapy and Oncology 106 (2013) 266–270In the late 1990s, after a period of shortage of radiotherapy
equipment with unacceptably long waiting times for patients,
the Dutch government allowed investments in treatment vaults,
radiotherapy equipment and an increased training capacity for
radiotherapy personnel. In addition, a reimbursement system
which takes the intensity and costs of different types of treatment
into account, was implemented.
In this study, we describe the developments in stafﬁng, amount
and type of equipment, and productivity over a 12 year time period
from 1998 to 2010. Additionally we compare the actual radiother-
apy ‘‘consumption’’ with predictions made throughout the years.Materials and methods
The Dutch Society for Radiation Oncology (NVRO) annually per-
forms a survey on production, personnel and equipment of the 21
Dutch radiotherapy centers. This includes questions on the number
and type of external beam and brachytherapy treatment series,
absolute number and number of full time equivalents of radiationion Oncology, VU University
am, The Netherlands.
.
er the Elsevier OA license.oncologists, clinical physicists, radiation technologists and support
personnel, number of persons in training and number of vacancies.
Questions on equipment include technical details for linear
accelerators, number of simulators, (PET)-CT scanners, MRI-
scanners and brachytherapy remote afterloaders. Additionally, in
2010 all radiotherapy centers were asked to report the number
of linear accelerators that was foreseen to be installed in the next
5 years.
These data, as well as data on productivity, measured as num-
ber of treatment series and intensity weighted treatment series
per accelerator, radiation oncologist, clinical physicist and radia-
tion technologists, are presented as national totals, without a spec-
iﬁcation per center.
Data from a Gammaknife center in the Netherlands are not in-
cluded. In the case of initial non-response, mailings and telephone
calls ensured a 100% response.
In the Dutch reimbursement system for radiotherapy intro-
duced in the late 1990s, treatments are categorized into four
groups for teletherapy (T1–T4) and four groups for brachytherapy
(B1–B4) [1]. A summary of the categories for teletherapy is given in
the footnote of Table 1. For each category, the costs of the treat-
ment have in the past been calculated in various types of radio-
therapy departments (academic, general and free-standing) and
averaged. If the standard category (T2) is set to 1, the cost ratios
Table 1
Radiotherapy series 1998–2010.
1998 2001 2004 2007 2010
n (%) n (%) n (%) n (%) n (%)
External beam series** 35,690 39,447 43,695 48,409 54,114
– T1 Simple 8450 23.7 9124 23.1 9546 21.8 10,521 21.7 11,473 21.2
– T2 Standard 20,364 57.1 20,341 51.6 18,940 43.3 12,433 25.7 10,249 18.9
– T3 3D Conformal 6022 16.9 7776 19.7 8753 20.0 13,268 27.4 11,484 21.2
– T4 Intensive (IMRT, SBRT, etc.) 1030 2.9 2115 5.4 6500 14.9 12,187 25.2 20,908 38.6
Weighted series* 36,123 42,431 55,534 73,487 89,677
Weighted series/total series 1.01 1.08 1.27 1.52 1.66
Brachytherapy series 2466 2379 3022 3418 3947
* The number of weighted series is calculated based on the relative costs of the four types of treatment (T1 = 0.3; T2 = 1.0; T3 = 1.7; T4 = 2.9).
** Summary of T-classiﬁcation for external beam radiotherapy:T1: short course (<14 fractions) in patients treated before.T2: course for new tumor, other than category T3 or
T4 T3: 3D conformal radiotherapy, mantle ﬁeld, CS-axis, or children.T4: intensive imaging and in vivo dosimetry, or stereotactic radiotherapy, IMRT, or IORT.
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treatment courses. The number of T2-equivalent treatments can
then be calculated by the formula: T2 equivalents = 0.3  T1 +
T2 + 1.7  T3 + 2.9  T4.
Both the Dutch Health Council and the NVRO made several pre-
dictions throughout the years to estimate the need of radiotherapy
capacity (1993, 2000, 2005, and 2011). Predictions were always
made for a period of 10–15 years. The estimation of the number
of radiotherapy treatments was based on the number of new can-
cer patients, which was available from the Dutch cancer registry
(1993, 2000) [2,3] or the Dutch Cancer Society (2005, 2011) [4,5].
This estimation was calculated as
Number of treatment series = NC  U  R  B where NC is the
number of new cancer patients per year, U is the utilization of
radiotherapy (fraction of new cancer patients receiving radiother-
apy), R is the repeat factor (average number of treatments courses
per patient, including retreatments), B is a factor that expresses
treatments for benign indications).
The number of required linear accelerators is then calculated
based on an average number of 500 weighted treatment series
per machine.Results
External beam radiotherapy
The number of external beam treatment series increased by
152% from 35,690 in 1998 to 54,114 in 2010 (Table 1). The annual
increase was 3.5–4.0%. The percentage of T4 treatment, mainly
consisting of IMRT, IGRT and stereotactic radiotherapy increased
from 2.3% in 1998 to 38.6% of all treatments in 2010. In 2010,
21.2% received 3D conformal radiotherapy with CT based contour-
ing and treatment planning. About 19% of the patients received a
standard treatment and 21% received a simple treatment, mainly
retreatments of metastases. The percentage of simple treatments
remained stable over the years, but standard treatments were
gradually replaced by 3D conformal treatments and 3D conformal
by intensity modulated and image-guided treatments. As de-
scribed above, using a weight factor based on the relative costs
of the four types of treatment, the weighted number of treatment
series was calculated. The number of weighted external beam ser-
ies increased from 36,123 in 1998 to 89,677 in 2010 (Table 1). The
relative weight of the external beam series (weighted series di-
vided by total series) increased from 1.01 in 1998 to 1.66 in 2010.Brachytherapy
As shown in Table 1, the number of brachytherapy treatments
increased by 160%. Between 1998 and 2001 there was a smalldecrease due to a smaller number of breast implants, but the num-
ber increased since then as a result of an increase in the number of
prostate brachytherapy series.Personnel
The number of radiation oncologists increased from 130.4 full
time equivalent (fte) in 1998 to 217.8 fte in 2010 (167%; circa 5%
per year). Over this time period, the number of clinical physicists
increased by circa 175% to 100.2 fte and of radiation technologists
by 151% to 961 fte (see Table 2). In 2010, there were 80 radiation
oncology residents (5 years program) and 27 clinical physicists
(4 year program) in training.Equipment
Between 1998 and 2010, the number of linear accelerators
(including two Tomotherapy units and a Cyberknife, which are in
the remainder of this publication counted as linacs) increased from
67 to 120 (179%). This increase was mainly realized between 2001
and 2007. As shown in Table 2, the percentage of dual energy
accelerators increased to 89% in 2010. The percentage of accelera-
tors which could deliver electron treatment showed a decrease
from 79% in 1998 to 68% in 2010. There was a signiﬁcant increase
in the percentage of accelerators with multileaf collimators (MLCs)
and electronic portal imaging devices (EPIDs). In 1998, MLCs and
EPIDs were present on 33% and 45% of the machines, respectively,
compared to more than 95% each in 2010. Currently active ma-
chines without these options are mainly dedicated machines, such
as for total body, total skin or stereotactic treatments. In 2007, 16%
of the multileaf collimators had leaf sizes of 5 mm or less (mea-
sured in the isocenter), whereas this increased to 28% in 2010. In
2007, 20% of all machines had a conebeam CT (CBCT) and this in-
creased to 38% in 2010. In 2010, 38% of the MV machines had been
installed less than 5 years ago and 50% 5–10 years ago.
There was a decrease in the number of orthovoltage treatment
units, from 24 in 1998 to 8 in 2010. These machines are currently
only used for treatments of superﬁcial skin tumors and for radiobi-
ological experiments. The number of simulators decreased from 38
in 1998 to 15 in 2010. In the same period, the number of dedicated
CT scanners in radiation oncology departments increased from 3 to
28. In 1998, only 2 of the 21 radiation oncology centers had their
own CT scanner, compared to 19 of the 21 in 2010.
As shown in Table 2, the number of brachytherapy remote after-
loaders decreased from 41 to 27. This was mainly due to a decrease
in the number of low dose rate afterloaders. The number of depart-
ments with brachytherapy afterloaders was stable over the years
(17 of the 21).
Table 2
Radiotherapy personnel in full time equivalents and radiotherapy equipment 1998–2010.
1998 2001 2004 2007 2010
n (%) n (%) n (%) n (%) n (%)
Radiation oncologists 130.4 145.1 167.0 190.7 217.8
Clinical physicists 57.1 60.3 74.8 87.4 100.2
Radiation technologists 638 715 849 906 961
Linear accelerators 67 75 94 110 120
– >1 energy 48 71.6 63 84.0 81 86.2 98 89.1 107 89.2
– Electrons 53 79.1 56 74.7 70 74.5 79 71.8 81 67.5
– Multileaf collimator 22 32.8 43 57.3 77 81.9 106 96.4 116 96.7
– Electronic portal imaging 30 44.8 53 70.7 84 89.4 106 96.4 115 95.8
– Cone beam CT 0 0.0 0 0.0 0 0.0 22 20.0 45 37.5
– Per 106 population 4.27 4.67 5.77 6.71 7.22
Cobalt units 3 1 0 0 0
Orthovoltage units 24 10 8 8 8
Simulators 38 37 32 25 15
– With ‘‘CT-option’’ 7 18.4 10 27.0 11 34.4 9 36.0 5 33.3
CT-scanners* 3 9 18 22 28
Brachytherapy remote afterloaders 41 39 36 30 27
– LDR 23 56.1 18 46.2 9 25.0 6 20.0 5 18.5
– PDR 5 12.2 7 17.9 11 30.6 9 30.0 8 29.6
– HDR 13 31.7 14 35.9 16 44.4 15 50.0 14 51.9
* The number of CT scanners included one PET-CT-scanner in 2007 and two in 2010.
268 Radiotherapy in the Netherlands 1998–2010The average size of the radiation oncology departments in-
creased from 3.2 linear accelerators in 1998 to 5.7 in 2010. In
1998, 18 of the 21 departments had 2 to 4 linear accelerators,
while in 2010, two departments had 2 or 3, nine had 4 or 5, ﬁve
had 6 or 7 and ﬁve had 8 or more accelerators.
On average, there were 6.2 fte radiation oncologists, 2.7 fte
physicists and 30.4 fte radiation technologists per department in
1998. This had increased to an average of 10.4 fte radiation oncol-
ogists, 4.8 fte physicists and 45.8 fte technologists per department
in 2010.70000Productivity
The productivity in absolute number of treatment series per
radiation oncologist showed a small decrease (274 series in 1998
to 249 series per radiation oncologist in 2010). Similarly, there
was a decrease in the number of treatment series per clinical phys-
icist, whereas the number of treatment series per radiation tech-
nologist was stable over the 12 year period (Table 3). Per linear
accelerator, 532 treatment series were realized in 1998, while this
decreased to 451 in 2010. If the relative intensity of the treatment
series is taken into account, the number of weighted series per
radiation oncologist increased from 277 to 412, per clinical physi-
cist from 633 to 895, per radiation technologist from 57 to 93, and
per linear accelerator from 539 to 747.Table 3
Absolute number of treatment series and number of weighted series per full time
equivalent and per linear accelerator.
1998 2001 2004 2007 2010
Absolute number
Per radiation oncologist 274 272 262 254 248
Per clinical physicist 625 654 584 554 540
Per radiation technologist 56 55 51 53 56
Per linear accelerator 533 526 465 440 451
Weighted treatment series
Per radiation oncologist 277 292 333 385 412
Per clinical physicist 633 704 742 841 895
Per radiation technologist 57 59 65 81 93
Per linear accelerator 539 566 591 668 747Predictions
The estimated and actual numbers of radiotherapy treatment
series per year compare very well (Fig. 1).
As shown in Table 4, the number of new cancer patients was
higher in each new prognosis. In the preparation of the 2007 prog-
nosis, it was noticed that the number of new cancer patients in the
Netherlands had increased more than previously anticipated. In
the 2000 prognosis, 63.1000 new cancer patients were expected
in 2005, and in the 2007 prognosis 78.500. To match the actual
numbers of treatment series in 2005 (around 45.000) with this
higher amount of new cancer patients, the utilization rate had to
be lowered (to 0.43). Fig. 2 shows that the actual number of linacs
between 1998 and 2010 matches the prognosticated number of
linacs.Discussion
In the period 1998–2010, the number of external beam treat-
ment series increased by 3.5–4.0 percent per year. There was a20000
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Fig. 1. Actual number and prognosis of the number of external beam treatment
series throughout the years in The Netherlands.
Table 4
Parameters for the prognosis of the number of radiotherapy treatments per year.
Year of prognosis: 2000
Year 2000 2005 2010
Number of new cancer patients 59,400 63,100 69,400
Utilization factor 0.48 0.49 0.50
Repeat factor 1.30 1.35 1.35
Benign diseases factor 1.050 1.050 1.050
Treatments per year 38,919 43,828 49,187
Year of prognosis: 2007
Year 2005 2010 2015
Number of new cancer patients 78,500 87,000 96,500
Utilization factor 0.43 0.44 0.45
Repeat factor 1.30 1.30 1.30
Benign diseases factor 1.035 1.035 1.035
Treatments per year 45,417 51,506 58,428
Year of prognosis 2011
Year 2010 2015 2020
Number of new cancer patients 95,538 110,215 123,021
Utilization factor 0.42 0.43 0.44
Repeat factor 1.30 1.30 1.30
Benign diseases factor 1.035 1.035 1.035
Treatments per year 53,989 63,767 72,831
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Fig. 2. Actual number and prognosis of the number of linacs throughout the years
in The Netherlands.
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apy and an increase in the percentage of IMRT, IGRT and stereotac-
tic courses. The latter treatments increased to almost 40% of all
external beam treatments.
The number of linacs increased as anticipated. Similarly, the
well-planned increase of training positions for radiation oncolo-
gists, physicists and technologists enabled an increase in stafﬁng
with only a limited number of vacancies. The study further demon-
strates the changes in speciﬁcations of the machines. The increase
in percentage of machines with MLCs and EPIDs was immediately
translated into changes in practice with more T3 and T4 series.
The number of brachytherapy remote afterloaders shows a
gradual decrease over the years, mainly due to a decrease in after-
loaders. The increase in brachytherapy series was mainly due to an
increase in permanent Iodine seeds implantations, not requiring
afterloaders.
The productivity per radiation oncologist showed a small de-
crease in absolute treatment series, but these series became much
more labor intensive. The same was observed for clinical physicists
and radiation technologists. The number of treatment series per
machine decreased by 15% from 532 to 451. This is probably the
net effect of more complex treatment, higher efﬁciency of delivery
of complex treatments and hypofractionation. More detailed infor-mation on the relative contribution of these factors is not available.
The number of linear accelerators per million inhabitants increased
from 4.27 in 1998 to 7.22 in 2010. In 2010, the number of machines
and the number of radiation oncologists, physicists and technolo-
gists per treatment series or patient, meet the guidelines as devel-
oped by IAEA [6] and ESTRO [7,8].
In 1998 most radiotherapy departments had long waiting lists
of sometimes more than 2 months for curative treatments. The
shortage of equipment did not allow the introduction of new tech-
nologies and limited an increased use of radiotherapy between
1995 and 2000 (Fig. 1), despite the constant increase of the number
of new cancer patients. In those years strict budgets for radiother-
apy were applicable. In 2010, there were virtually no waiting lists
and IGRT and IMRT were implemented in most departments and
about half of the departments performed stereotactic treatments.
This type of annual surveys can be very useful for evaluating
and predicting the radiotherapy needs. In the Netherlands, the
number of MV machines and personnel in radiotherapy has in-
creased signiﬁcantly over the study period. This was deliberately
realized without an increase in the number of centers, resulting
in a fast growth of treatment capacity and resulting in larger radio-
therapy centers. This allowed sufﬁcient sub-specialization of the
staff in order to cover all tumor areas at a high level. Since the tech-
nical developments occur much faster than the economical lifetime
of a linear accelerator, larger radiotherapy centers, which replace
one or more machines every few years, enable the introduction
of new technology at a much faster rate.
In the last few years, a number of satellite centers have been
opened. All satellite centers are established by, or operate under
the responsibility of, existing centers, thus allowing a proper
spread of linacs in combination with high quality radiotherapy.
New satellites will be opened in the next few years. The Dutch
Society of Radiation Oncology has developed guidelines for centers
that plan such satellites to guarantee a high quality level when
treatments are given at different locations. According to these
guidelines, the main center should have a minimum of 4 linear
accelerators and a staff of at least 8 radiation oncologists and 3
clinical physicists. In addition treatment planning should be per-
formed at the main site, each satellite should have at least 2 MV
machines of which the beams are matched to the beams in the
mean center. There should be one quality system for both the main
center and satellite(s), which guarantees the use of identical clini-
cal protocols for all locations.
270 Radiotherapy in the Netherlands 1998–2010Studies in France [9] and Spain [10] performed in the late 1990s
showed a shortage of radiotherapy equipment and personnel, with
large differences between regions and a high number of small cen-
ters in more remote areas. Similarly, a recent Australian study also
showed large regional differences in availability and consequently
use of radiotherapy [11]. The recent Dutch approach of larger main
centers with one or more afﬁliated satellites, working together as
one institute, could also be appropriate in regions with heavily dis-
persed populations as a way to combine a high quality standard for
radiotherapy with an adequate spread of radiotherapy centers. A
study from rural Australia has shown that even units with a single
machine, operating as satellites of larger centers, can deliver simi-
lar standards of care [12].
The increase of the number of radiotherapy facilities was
planned according to a detailed prognosis of the required number
of linacs and the number of radiation oncologists and clinical
physicists. This study shows that the number of radiotherapy treat-
ments can be very well prognosticated over a period of 5–10 years.
Only slight modiﬁcations in the conversion parameters were
necessary. The most variable factor was the number of new cancer
patients. For the planning of the number of training positions for
radiation oncologists and physicists, a more detailed calculation,
similar to the model described by Stuckless et al. [13] is used. This
is of great important to avoid shortage of personnel as reported for
Australia [14], but also to avoid unemployment of highly special-
ized personnel. In this calculation, the age distribution of person-
nel, parttime factor, etc. are taken into account as well.
From 2005 an increasing discrepancy between prediction and
reality was observed for the number of clinically available linacs.
In these years hypofractionated treatment schemes were intro-
duced in many clinics in The Netherlands, for instance for curative
treatments of breast and prostate cancer. In addition stereotactic
treatments were introduced on a larger scale. Prediction and ‘‘real-
ity’’ ﬁt very well if these adaptions are incorporated in the predic-
tion for the number of linacs that will be required.
The use of the prognosticated number of treatments, realized
conversion factors from treatment to capacity and the incorpora-
tion of expected changes in fractionation schemes allow an ad-
vanced planning of machines and human resources for a periodof 5–10 years. This enables sufﬁcient availability to meet the de-
mands without causing ‘overcapacity’.
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